181 related items for PubMed ID: 30767017
1. Recovery Room Cortisol Predicts Long-Term Glucocorticoid Need After Transsphenoidal Surgery for Pituitary Tumors.
Qaddoura A, Shalung TN, Meier MP, Goguen J, Jing R, Zhang S, Kovacs K, Cusimano MD.
Neurosurgery; 2019 Mar 01; 84(3):616-623. PubMed ID: 30767017
[Abstract] [Full Text] [Related]
2. Early morning cortisol levels as predictors of short-term and long-term adrenal function after endonasal transsphenoidal surgery for pituitary adenomas and Rathke's cleft cysts.
McLaughlin N, Cohan P, Barnett P, Eisenberg A, Chaloner C, Kelly DF.
World Neurosurg; 2013 Nov 01; 80(5):569-75. PubMed ID: 22902358
[Abstract] [Full Text] [Related]
3. Use of morning serum cortisol level after transsphenoidal resection of pituitary adenoma to predict the need for long-term glucocorticoid supplementation.
Marko NF, Gonugunta VA, Hamrahian AH, Usmani A, Mayberg MR, Weil RJ.
J Neurosurg; 2009 Sep 01; 111(3):540-4. PubMed ID: 19326985
[Abstract] [Full Text] [Related]
4. Day 5 morning serum cortisol predicts hypothalamic-pituitary-adrenal function after transsphenoidal surgery for pituitary tumors.
Jayasena CN, Gadhvi KA, Gohel B, Martin NM, Mendoza N, Meeran K, Dhillo WS.
Clin Chem; 2009 May 01; 55(5):972-7. PubMed ID: 19282356
[Abstract] [Full Text] [Related]
5. Dynamics of postoperative serum cortisol after transsphenoidal surgery for Cushing's disease: implications for immediate reoperation and remission.
Mayberg M, Reintjes S, Patel A, Moloney K, Mercado J, Carlson A, Scanlan J, Broyles F.
J Neurosurg; 2018 Nov 01; 129(5):1268-1277. PubMed ID: 29271716
[Abstract] [Full Text] [Related]
6. MORNING SERUM CORTISOL LEVEL AFTER TRANSSPHENOIDAL SURGERY FOR PITUITARY ADENOMA PREDICTS HYPOTHALAMIC-PITUITARY-ADRENAL FUNCTION DESPITE INTRAOPERATIVE DEXAMETHASONE USE.
Manuylova E, Calvi LM, Vates GE, Hastings C, Shafiq I.
Endocr Pract; 2015 Aug 01; 21(8):897-902. PubMed ID: 26121454
[Abstract] [Full Text] [Related]
7. UTILITY OF A GLUCOCORTICOID SPARING STRATEGY IN THE MANAGEMENT OF PATIENTS FOLLOWING TRANSSPHENOIDAL SURGERY.
Jia X, Pendharkar AV, Loftus P, Dodd RL, Chu O, Fraenkel M, Katznelson L.
Endocr Pract; 2016 Sep 01; 22(9):1033-9. PubMed ID: 27124693
[Abstract] [Full Text] [Related]
8. Rational use of glucocorticoid during pituitary surgery--a pilot study.
Bhansali A, Dutta P, Bhat MH, Mukherjee KK, Rajput R, Bhadada S.
Indian J Med Res; 2008 Sep 01; 128(3):294-9. PubMed ID: 19052341
[Abstract] [Full Text] [Related]
9. Prospective evaluation of a protocol for reduced glucocorticoid replacement in transsphenoidal pituitary adenomectomy: prophylactic glucocorticoid replacement is seldom necessary.
Wentworth JM, Gao N, Sumithran KP, Maartens NF, Kaye AH, Colman PG, Ebeling PR.
Clin Endocrinol (Oxf); 2008 Jan 01; 68(1):29-35. PubMed ID: 18088287
[Abstract] [Full Text] [Related]
10. Perioperative serum cortisol levels in ACTH sufficient and ACTH deficient patients during transsphenoidal surgery of pituitary adenoma.
Borg H, Siesjö P, Kahlon B, Fjalldal S, Erfurth EM.
Endocrine; 2018 Oct 01; 62(1):83-89. PubMed ID: 29968225
[Abstract] [Full Text] [Related]
11. Which patients benefit from provocative adrenal testing after transsphenoidal pituitary surgery?
Auchus RJ, Shewbridge RK, Shepherd MD.
Clin Endocrinol (Oxf); 1997 Jan 01; 46(1):21-7. PubMed ID: 9059554
[Abstract] [Full Text] [Related]
12. [Selective use of glucocorticoids during the perioperative period of transsphenoidal surgery for pituitary tumors].
Carrasco CA, Villanueva G P.
Rev Med Chil; 2014 Sep 01; 142(9):1113-9. PubMed ID: 25517050
[Abstract] [Full Text] [Related]
13. Use of day 1 early morning cortisol to predict the need for glucocorticoid replacement after pituitary surgery.
Bondugulapati LN, Campbell C, Chowdhury SR, Goetz P, Davies JS, Rees DA, Hayhurst C.
Br J Neurosurg; 2016 Sep 01; 30(1):76-9. PubMed ID: 26313503
[Abstract] [Full Text] [Related]
14. Second-Day Morning Cortisol Levels after Transsphenoidal Surgery Are Accurate Predictors of Secondary Adrenal Insufficiency with Diagnostic Cut-Offs Similar to Those in Non-Stressed Conditions.
Prencipe N, Parasiliti-Caprino M, Gatti F, Penner F, Berton AM, Bona C, Caputo M, D'Angelo V, Cappiello V, Gasco V, Ghigo E, Zenga F, Grottoli S.
Neuroendocrinology; 2021 Sep 01; 111(7):639-649. PubMed ID: 32492678
[Abstract] [Full Text] [Related]
15. Postoperative plasma cortisol levels predict long-term outcome in patients with Cushing's disease and determine which patients should be treated with pituitary irradiation after surgery.
Imaki T, Tsushima T, Hizuka N, Odagiri E, Murata Y, Suda T, Takano K.
Endocr J; 2001 Feb 01; 48(1):53-62. PubMed ID: 11403103
[Abstract] [Full Text] [Related]
16. Evaluation of the hypothalamic-pituitary-adrenal axis immediately after pituitary adenomectomy: is perioperative steroid therapy necessary?
Hout WM, Arafah BM, Salazar R, Selman W.
J Clin Endocrinol Metab; 1988 Jun 01; 66(6):1208-12. PubMed ID: 3372683
[Abstract] [Full Text] [Related]
17. Long-term outcomes of tissue-based ACTH-antibody assay-guided transsphenoidal resection of pituitary adenomas in Cushing disease.
Erfe JM, Perry A, McClaskey J, Inzucchi SE, James WS, Eid T, Bronen RA, Mahajan A, Huttner A, Santos F, Spencer D.
J Neurosurg; 2018 Sep 01; 129(3):629-641. PubMed ID: 29027854
[Abstract] [Full Text] [Related]
18. Pituitary-adrenal dynamics after ACTH-secreting pituitary tumor resection in patients receiving no steroids post-operatively.
Pimentel-Filho FR, Silva ME, Nogueira KC, Berger K, Cukiert A, Liberman B.
J Endocrinol Invest; 2005 Jun 01; 28(6):502-8. PubMed ID: 16117190
[Abstract] [Full Text] [Related]
19. Recovery of the Hypothalamo-Pituitary-Adrenal Axis After Transsphenoidal Adenomectomy for Non-ACTH-Secreting Macroadenomas.
Pofi R, Gunatilake S, Macgregor V, Shine B, Joseph R, Grossman AB, Isidori AM, Cudlip S, Jafar-Mohammadi B, Tomlinson JW, Pal A.
J Clin Endocrinol Metab; 2019 Nov 01; 104(11):5316-5324. PubMed ID: 31225871
[Abstract] [Full Text] [Related]
20. Transsphenoidal microsurgical treatment of Cushing disease: postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression test.
Chen JC, Amar AP, Choi S, Singer P, Couldwell WT, Weiss MH.
J Neurosurg; 2003 May 01; 98(5):967-73. PubMed ID: 12744355
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
